OraSure Announces Record Revenues for Full-Year and Fourth Quarter 2015

Go back to OraSure Announces Record Revenues for Full-Year and Fourth Quarter 2015

Canaccord Genuity Reiterates Buy as OraSure Technologies (OSUR) Reports 4th Consecutive Quarter of Profit

February 4, 2016 9:59 AM EST

Canaccord Genuity reiterated a Buy rating and $8 price target on OraSure Technologies (NASDAQ: OSUR) following the company's 4Q earnings report. OSUR posted revenue of $32.4M, handily beating the Street's $29.8M estimate, as strength in the molecular collections systems segment and HCV sales... More